Trial Details

COMPLETED
Basic Information
Clinical ID c4495
Identifier NCT00427921
Trial Title Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions BIOLOGICAL: adalimumab
Participant Information
Sponsor Abbott
City Abbott Park
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2007-01
Primary Completion Date 2008-01
Completion Date 2008-01